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The widespread UbiD enzyme family utilises the prFMN cofactor to achieve reversible
decarboxylation of acrylic and (hetero)aromatic compounds. The reaction with acrylic
compounds based on reversible 1,3-dipolar cycloaddition between substrate and prFMN
occurs within the confines of the active site. In contrast, during aromatic acid decarboxyla-
tion, substantial rearrangement of the substrate aromatic moiety associated with covalent
catalysis presents a molecular dynamic challenge. Here we determine the crystal structures
of the multi-subunit vanillic acid decarboxylase VdcCD. We demonstrate that the small VdcD
subunit acts as an allosteric activator of the UbiD-like VdcC. Comparison of distinct VdcCD
structures reveals domain motion of the prFMN-binding domain directly affects active site
architecture. Docking of substrate and prFMN-adduct species reveals active site reorgani-
sation coupled to domain motion supports rearrangement of the substrate aromatic moiety.
Together with kinetic solvent viscosity effects, this establishes prFMN covalent catalysis of
aromatic (de)carboxylation is afforded by UbiD dynamics.
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The processing and utilisation of abundant (hetero)aromaticcompounds derived from biomass is a sustainable alter-native that reduces reliance on oil derived compounds1–4.
Recent studies have demonstrated that UbiD enzymes can be
used for (hetero)aromatic C–H activation at ambient conditions,
providing a route to corresponding acids and derivative
compounds5–7. Studies have also shown the potential of using
UbiD enzymes in cascades in the production of cis,cis–muconic
acid8,9 and in 1,3-butadiene production10; both valuable chemi-
cals in the production of synthetic polymers.
The UbiD enzyme family is ubiquitous in microbes and is
frequently associated with the flavin prenyltransferase, UbiX. The
latter produces the prFMN cofactor required for the UbiD-
mediated reversible decarboxylation of unsaturated acids (Sup-
plementary Fig. 1)11. The UbiD enzyme family can operate on a
wide range of unsaturated acrylic, aromatic and heteroaromatic
acids, although individual UbiD enzyme substrate specificity has
proven to be relatively narrow12. Whilst most enzymes function
as decarboxylases under physiological conditions, some anaerobic
organisms initiate degradation of recalcitrant aromatic com-
pounds such as benzene or naphthalene via UbiD mediated
carboxylation13–15.
A range of studies with the model system fungal Fdc1 (ferulic
acid decarboxylase) have established that a reversible 1,3-dipolar
cycloaddition between the acrylic acid dipolarophile and the
prFMNiminium azomethine ylide occurs via three distinct
intermediates16,17 (Fig. 1a). Recent protein engineering studies
have established Fdc1 can be evolved to accept carboxylated
(hetero)aromatic compounds (i.e. where Cα contributes to the
(hetero)aromatic ring), although catalytic rates remain low5.
Covalent catalysis with (hetero)aromatic substrates requires
transient dearomatisation of the substrate. A range of mechanisms
have been proposed for those UbiD enzymes that catalyse dec-
arboxylation of phenolic (Fig. 1b)18 and heteroaromatic acids
(Fig. 1c)6,19. These all propose formation of a series of covalent
adducts between the prFMN C1’ and the substrate Cα (i.e. Int1, 2
and 3). In the case of the Fdc1 mediated reaction with acrylic
acids, the structure of various intermediates reveals considerable
strain is imposed by the active site, guiding the reaction along17.
However, in the case of aromatic substrates, it remains unclear
how the enzyme active site can accommodate the substantial
rearrangement of the aromatic moiety that accompanies the
transition between various prFMN-adduct intermediates. Fur-
thermore, the inherent stability of the Int2 species afforded by re-
aromatisation of the substrate moiety (as compared to Int1 and 3)
presents an inherent obstacle to rapid turnover.
It has been suggested that UbiD aromatic acid decarboxylases
could accommodate the postulated substrate rearrangement by
virtue of domain motion dynamics18,20. Indeed, the active site sits
at the interface of the prFMN binding and oligomerisation
domains, and distinct UbiD enzyme structures fall into either
open or closed conformational states (Fig. 1d). However, only the
PA0254 (also known as HudA) enzyme has previously been
shown to adopt both conformations with the transition between
both conformations apparently linked to cofactor binding19.
Hence, only the dimeric and oxygen-tolerant Fdc1 and PA0254
are representatives of the proposed closed state and are accom-
panied by substrate or ligand complex structures. In contrast, the
hexameric and oxygen-sensitive (hetero)aromatic (de)carbox-
ylases such as HmfF, AroY, and UbiD for which crystal structures
are available all adopt open conformations and have yet to yield
detailed insights into substrate binding6,18,20; the substrates of
these enzymes are detailed in Supplementary Table 1.
Furthermore, aside from the obligate requirement for UbiX
shared by all UbiDs, a number of the aromatic acid (de)carbox-
ylases are reported to require additional proteins for activity. The
vanillic acid decarboxylases for example require a small
(<~10 kDa) accessory protein VdcD for activity, in addition to the
UbiD homolog VdcC21. While some UbiD accessory proteins
have annotated functions (such as the phosphatase and kinase
associated with the phenol phosphate carboxylase enzyme22), the
role of many of the smaller proteins remains unknown. Inter-
estingly, there is no sequence similarity between VdcD, the
phenol phosphate carboxylase small subunit (PpcGamma), or
LpdD involved in gallic acid decarboxylation in Lactobacillus
plantarum23.
Here we detail crystal structures of the Sedimentibacter
hydroxybenzoicus VdcCD enzyme and demonstrate that VdcC
forms a tight complex with VdcD, a zinc ribbon protein that
allosterically regulates VdcC activity. A comparison of distinct
VdcCD crystal structures reveal the presence of open and closed
states and establishes that VdcC can undergo a large scale
prFMN-binding domain motion, dramatically affecting active site
volume. Combined with docking studies and kinetic solvent
viscosity effects, our data reveals the structural reorganisation
coupled to domain motion supports the rearrangement of the
substrate aromatic moiety. This establishes prFMN covalent
catalysis of aromatic (de)carboxylation is afforded by UbiD
dynamics.
Results
A VdcCD complex is required for activity. His-tagged versions
of the VdcC proteins from Bacillus subtilis (BsVdcC) and Sedi-
mentibacter hydroxybenzoicus (ShVdcC; formerly Clostridium
hydroxybenzoicum24) were co-expressed with Pseudomonas aer-
uginosa UbiX in Escherichia coli (BL21 DE3). However, following
purification, the UV-vis spectrum of the isolated preparations did
not provide any evidence of cofactor binding. We tested the
decarboxylation activity of both VdcC enzymes reconstituted
in vitro with prFMN using vanillic acid and 4-hydroxybenzoic
acid (PHB) as substrates. Little to no activity was detected for
either VdcC (Fig. 2a), in line with previous reports that VdcD is
essential for activity25,26. The corresponding His-tagged VdcD
subunits were therefore expressed in E. coli, and purified VcdD
was added to VdcC preparations prior to in vitro prFMN
reconstitution. When assayed, the VdcC+VdcD reconstituted
samples demonstrated considerable activity in contrast to isolated
VdcC. This demonstrates a strict requirement of both VdcC and
VdcD for activity. We tested the effect of VdcC:VdcD stoichio-
metry on activity levels of the Sedimentibacter hydroxybenzoicus
enzyme. It was found that, while keeping the concentration of
VdcC constant, a sub-stoichiometric 0.2:1 D:C ratio led to sub-
stantially lower activity when compared with excess D (4:1 D:C
ratio) conditions (Fig. 2b). This suggests that VdcD is likely to
form an integral part of the catalytic species, as opposed to a
transient role in the VdcC-prFMN complex maturation, for
example. To confirm that a VdcCD complex is formed, we
respectively co-expressed both BsVdcC/D and ShVdcC/D
enzymes, whereby only one of the subunits was tagged with a
hexa-histidine tag. We found that tagging of either VdcC or D
subunit resulted in co-purification of both proteins, yielding the
VdcCD complex in both cases. Unfortunately, despite co-
expression of UbiX, this procedure did not yield the holo-
VdcCD without in vitro reconstitution.
The VdcCD prFMN cofactor is inactivated by oxygen. To
confirm previous reports of VdcCD oxygen sensitivity, we
reconstituted ShVdcCD under anaerobic conditions with
prFMNH2. The holo-VdcCD was exposed to aerobic conditions
and initial decarboxylation activity with PHB was measured at
multiple time points over a 90 min period. Activity decayed with
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an approximate half-life of 40 minutes (Fig. 2c). Following 90 min
oxygen exposure, addition of 2-fold excess of prFMNH2 led to
significant recovery of activity and demonstrates that the oxygen
inactivation of VdcCD occurs at the level of the cofactor. In the
case of phthaloyl co-A decarboxylase, it is postulated oxidation of
the prFMN associated metal ion (Fe(II) in this case) leads to a
simple loss of the cofactor27. However, it is unlikely oxidation of
Mn2+ underpins oxygen inactivation of VdcCD as the addition of
cofactor alone (without additional Mn2+) is sufficient in restoring
activity.
VdcCD crystal structure reveals a tight association between
both subunits. The apo-ShVdcCD complex was crystallised
under a number of conditions, with different crystal forms
yielding diffraction data at a resolution ranging from 2.2 Å to
3.4 Å. Despite multiple attempts, no crystals of individual sub-
units or the holo-ShVdcCD complex could be obtained. The
ShVdcCD structures were solved using molecular replacement
with individual domains of the E. coli (K12) UbiD as the search
models (PDB code 5M1C). The ShVdcCD crystal structures
contain a ShVdcC hexamer decorated with 6 small ShVdcD
subunits (Fig. 3a). The ShVdcD was found to bind a zinc ion in a
tetrahedral coordination with four cysteine residues (ShVdcD
numbering C3, C6, C28 and C31) (Fig. 3b). The 4 Cys residues
are arranged in two CXXC knuckle motifs, an arrangement
common for zinc ribbon proteins28. Indeed, ShVdcD forms a
three stranded, antiparallel β-sheet, and shares structural simila-
rities with the zinc ribbon protein TF-IIS as identified by
PDBeFold29 (RMSD – 1.77 Å over 37 residues - PDB accession-
1TFI30). Both the β-sheet of ShVdcD as well as the proline rich
C-terminal tail region interact with the surface of ShVdcC. The
ShVdcC:D interface was analysed by PISA31 and was shown to
have an average area of 1661 Å2, involving 40 residues of ShVdcD
(59% of total residues), and 50 residues of ShVdcC (10.5% of total
residues). In addition to a number of hydrogen bonds and van der
Waals interactions, intersubunit salt bridges were identified with
ShVdcD R12, R36 and E39 forming interactions with ShVdcC
D173, E31 and R133. Sequence analysis of multiple VdcD show
that the two CXXC motifs are conserved, therefore Zn2+ binding
is likely an essential structural motif to maintain the sheet for-
mation and interaction with ShVdcC. The location of the
ShVdcC: ShVdcD interface suggests that the allosteric effect is
based on maintaining the structure of the key catalytic ERE
Fig. 1 Mechanism and structures of the UbiD enzyme family. a Proposed 1,3 dipolar cycloaddition Fdc1 mechanism16,17. b A substrate nucleophilic attack
mechanism proposed for phenolic substrates18. c Electrophilic aromatic substitution mechanism postulated for PA0254-mediated decarboxylation of
pyrrole-2-carboxylate19. All mechanisms share a common Int2 intermediate with an sp2 hybridized substrate Cα. Transient dearomatisation occurring for
Int1 and Int3 species presents a significant energy barrier in each case. prFMN-R= phosphoribityl moiety (omitted for clarity) d Overlay of UbiD
monomers anchored on the prFMN binding domain (in blue). The oligomerisation domains of Fdc and PA0254 are shown in orange (representing a closed
conformation), while UbiD, HmfF and AroY are shown in open states (in red). The C-terminal helix is shown in grey. The hinge region is located within a
helix (in green) connecting the oligomerisation and prFMN binding domains, close to bound cofactor (in yellow spheres).
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Fig. 2 Activity of Vdc proteins. a Activity of reconstituted Vdc proteins. Significant activity is only seen when both VdcC and VdcD are present. Protein
obtained through co-purification is denoted as VdcCD. Where proteins were purified separately and combined in vitro, the label VdcC+VdcD is used.
Substrate specificity of VdcCD enzymes from Bacillus subtilis and Sedimentibacter hydroxybenziocus show similar substrate ranges, with the exception of
syringic acid. Non-cognate VdcD can be used for the limited activation of VdcC. Deletion of the proline rich tail of VdcD has little effect on the activity of
VdcCD. Data shown as mean ± SEM n= 2 independent replicates. b Effect of VdcC:VdcD ratio on decarboxylation rates of 100 µM PHB. A sub-equimolar
ratio results in slower decarboxylation of PHB, suggesting a non-transient interaction between VdcC and VdcD. Data are represented by mean ± SEM, n= 3
technical replicates. Data trends seen in three independent replicates. c Decrease in activity of ShVdcCD with 100 µM PHB in aerobic conditions. Addition
of prFMNH2 partially restores activity, all data points shown, bar represents mean. Data from two independent replicates.
Fig. 3 Structures of VdcCD complexes in open and closed states. a Left – Open hexamer of ShVdcCD, Right – closed hexamer of ShVdcCD. A single
monomer of ShVdcC is coloured by domain (red – oligomerisation domain, blue – prFMN binding domain) with ShVdcD in light blue. All other ShVdcC in
the complex are shown in light grey, with ShVdcD shown in dark grey. b Interaction of ShVdcC and ShVdcD showing the proximity of VdcD binding to the
VdcC active site. VdcD interacts with loops containing the key ERE residues which are a key triad for catalysis, VdcD likely serves to maintain the
positioning of these residues. prFMN (in cyan) is modelled in the active site based on a structural alignment with holo-Fdc1 (4ZA4). Inset shows the VdcD
tetrahedral binding of Zn2+ by four conserved cysteine residues. Polder map corresponding to Zn2+ contoured at 5 sigma. c Dyndom analysis reveals a 32°
rotation at the T325 and S326 hinge region (in green) connects the open (left) and closed states (right). Other domains coloured as in a, with the
C-terminal helix coloured in grey.
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motif32 (Fig. 3b). Intriguingly, despite the relatively low sequence
identity of 39% (48% similarity) between the VdcD subunits,
limited activation of the C subunit could be achieved with the
addition of a non-cognate D subunit (Fig. 2a).
Distinct VdcCD crystal structures reveal prFMN domain
motion. A comparison of the ShVdcC monomers across the
ShVdcCD crystal structures obtained reveals that the prFMN
binding domain adopts different conformations with respect to
the oligomerisation domain, confirming the existence of distinct
open and closed states (Supplementary movie 1 illustrates the
motion between the open and closed hexamers). The distinct
states occur independent of both prFMN cofactor and VdcD
binding (both states occur for the apo-VdcCD complex), in
contrast to the apo-open and holo-closed PA0254 structures
where domain motion appears linked to cofactor binding19.
ShVdcCD structures thus allow for detailed inspection of the
transition between the two states. An analysis of the domain
motion using DynDom33 identifies this as a hinge motion, with
the point of rotation located at T325 and S326, located in an α-
helix connecting the oligomerisation and prFMN binding
domains (Fig. 3c). This helix has been previously postulated as
the point of flexibility in E. coli UbiD20 and AroY18 on the basis
of the small hinge motions observed by comparing various open
state monomers. In the case of PA0254, overlays of the respective
apo- and holo-structures also requires a similar hinge motion19.
In VdcCD, the hinge rotation angle is approximately 32°, with
only a negligible translation of the domains (<1 Å). The number
of interdomain contacts of the closed state outnumber those of
the open state, with 11 more paired residue contacts, the majority
occurring close to the active site (Supplementary Fig. 2).
The distance between the centre-of-mass (calculated by the
CALCOM server34) of residues R168/173 (ShVdcC/Fdc number-
ing) on the prFMN binding domain and L425/439 on the
oligomerisation domain can be used as a simple indicator of open
or closed conformation (Supplementary Fig. 3a). These residues
are highly conserved in the UbiD family and have been
demonstrated to be essential in catalysis by Fdc117,32. In the
open ShVdcCD the mean distances (±SD) are 14.5 ± 0.1 Å (P1
crystal form) and 14.1 ± 1.4 Å (P212121 crystal form), compared
to 9.3 ± 0.1 Å for the closed (F222) form. When determining the
distance between the corresponding residues in other UbiD
structures, only Fdc1 and holo-PA0254 crystal structures clearly
correlate to a closed state (9.8 Å and 10.1 ± 0.1 Å respectively),
while distances for AroY, UbiD, HmfF and TtnD are distributed
over a wide range corresponding to the open conformation
(Supplementary Fig. 3b).
Modelling of holo-VdcCD complexes. An overlay of the struc-
ture of a closed ShVdcCD structure with the model UbiD enzyme
Aspergillus niger Fdc1 (PDB 4ZA4), allows for the ShVdcCD
prFMN binding site to be easily located and active site residues
identified. Docking prFMN to the closed ShVdcCD structure
using Molsoft ICM Pro (version 3.9-2b) and Rosetta Ligand
Docking35,36 resulted in a similar binding conformation (Fig. 4a).
All residues implicated in catalysis, including the UbiD-conserved
E(D)RE motif integral for activity, are present in ShVdcCD.
We were able to assess binding of vanillic acid in ShVdcCD by
superimposition with the naphthoic acid (6TIB) AnFdc complex5
(Supplementary Fig. 4). The proposed substrate binding mode
suggests H349 and Y381 position the substrate of the Cα-Cβ bond
in ideal geometry in relation to C1’ and C4a and could support
substrate phenolate formation during catalysis. To assess the
impact of domain motion on catalysis, we assessed the binding of
substrate and prFMN adducts to intermediate structures along
the trajectory of closure (generated using Chimera Morph
between the open and closed states37) by docking using
AutoDock Vina38. The morph model used for docking was
validated by assessing the domain motion using low-frequency
normal mode analysis performed with elNémo39 (Supplementary
movie 2), which shows similar domain motions. The catalytic
glutamate residue (E278) adopts a range of conformations in
other UbiD enzymes, adapting to the presence and nature of
ligands bound in the active site. For this reason, the E278 rotamer
was altered to avoid clashes when docking carboxylated
compounds. Docking PHB to the holo-VdcCD reveals inter-
mediate states (i.e. R-L distance= 11.6 Å) result in lowest energy,
whereas docking vanillic acid reveal that R-L distances of 13.4 Å
show the lowest energy (Fig. 4b). However, the relative position of
the substrate with respect to prFMN is subtly altered by the
domain closure, and resembles previously determined Fdc1
ligand complexes most closely at R-L distances of 10.4 Å and
10.0 Å for PHB and vanillic acid respectively (Fig. 4c). Hence,
domain closure likely minimizes the substrate Cα/prFMN C1’
distance prior to Int1 formation.
DFT generated models of the PHB adducts Int2 and Int3Quinoid
(Int1Quinoid spontaneously decarboxylates) were docked to apo-
VdcCD structures along the domain closure trajectory. The Int2
complex has the lowest energy for the longer R-L distances, while
Int3Quinoid complex displays an energy minimum at R-L distance
~10 Å (Figs. 4b and 5). Hence, docking analysis suggests domain
motion accompanies the Int 1/3Quinoid transition to Int2.
Furthermore, it is possible domain closure leads to a strained
conformation of Int2, thus assisting conversion to Int1/3Quinoid
and ultimately product formation.
Kinetic solvent viscosity effects support a VdcCD dynamic
model. To determine whether catalysis is coupled to proposed
domain motions, we determined the kinetic parameters of PHB
decarboxylation by ShVdcCD in the presence of viscosogens. It
was found that kcatapp was drastically reduced in 45% (v/v) gly-
cerol or 40% (w/v) sucrose conditions (Fig. 4d). In contrast, the
Kmapp for PHB is not significantly impacted within the error of
the data, suggesting neither microviscosogen acts as competitive
inhibitor. The decrease of kcatapp with relative viscosity (η) sup-
ports the proposed VdcCD dynamic model for catalysis with
increased viscosity affecting domain motion40.
The VdcD unit does not directly contribute to catalysis. Only a
single ShVdcD residue (I60) can be considered to contribute to
the active site architecture (Figs. 3b and 4a). This residue is
located on a conserved proline rich tail located at the ShVdcCD
interface. We sought to investigate the role of this C-terminal tail
by deleting ShVdcD residues 59–68 (VIPPIPPLKK). The resulting
ShVdcCDV59X complex was determined to be active, with dec-
arboxylation yields only slightly diminished (i.e. <10% reduction
in yield) compared to those of the wild type (Fig. 2a).
ShVdcCDV59X crystallised in a different space group (P212121)
from the WT open (P1) and closed (F222) forms. The
ShVdcCDV59X P212121 structure contains a single hetero-
dodecamer in the asymmetric unit, with the majority of indivi-
dual ShVdcC monomers adopting an open form. A comparison
to the wild type structure shows little difference in the relative
positions of the active site residues, with the exception of a minor
shift in residues directly adjacent to the deleted tail region. The
observation that ShVdcD does not appear to directly contribute to
the active site architecture supports the notion that its role is
mainly in the stabilisation of the catalytic ERE containing loop
regions at the ShVdcCD interface.
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VdcCD substrate specificity. The substrate scope of both
BsVdcCD and ShVdcCD were determined by endpoint assays,
incubating the enzymes overnight with 5 mM substrate prior to
quenching the reaction. The substrate scope of these enzymes is
shown to be similar, as expected given the 58% identity between
ShVdcCD and BsVdcCD (Fig. 2a). Notable exceptions are syr-
ingic acid, for which product formation could only be detected in
the presence of BsVdcCD, and gallic acid which only supported
minor activity with ShVdcCD. This can be explained by con-
sideration of the respective active site structures. The BsVdcCD
active site volume is larger due to the substitution of Met423 for
Leu419 and Leu182 for Val179 on the C subunit, as well as the D
subunit Ile60 replaced by Val67 (Supplementary Fig. 5). This
presumably allows for correct positioning of the second methoxy
group of syringic acid. An L182V mutant of ShVdcCD was found
to be capable of syringic acid decarboxylation with 6.5 ± 0.6%
turnover compared to no turnover seen in the wild type protein,
thus further validating the proposed substrate binding model.
Discussion
The covalent catalysis used by the prFMN-dependent enzymes
presents a range of challenges to ensure rapid turnover. In the
case of the fungal Fdc1 enzyme, considerable strain imposed by
the rigid active site for various intermediates along the pathway
has been observed17. This is proposed to support the reversible
nature of the 1,3-dipolar cycloaddition process and avoid the
formation of dead-end adduct species. While these are avoided
for the relatively large substrates, dead-end adducts are formed
with the considerably smaller crotonic acid, presumably because
the enzyme is unable to exert strain in this case. The aromatic
acid UbiD decarboxylases are faced with a range of challenges.
These including the need to surmount the inherent aromatic
stability of the substrate, the requirement to accommodate the
relatively large motion of the substrate aromatic moiety upon
progression through the various prFMN-covalent adducts, as well
as the ability to manipulate the internal thermodynamics of the
reaction to avoid highly stable aromatic Int2 species following
decarboxylation/deprotonation.
We demonstrate that UbiD-enzymes have the scope to adapt
the shape of the active site via domain motion by determining
structures of open and closed states for the vanillic acid dec-
arboxylase VdcCD (Fig. 5). While the VdcCD closed state
resembles the conformation observed for fungal Fdc1, the open
state resembles the majority of UbiD structures hitherto deter-
mined. Modelling of the VdcCD domain closure trajectory and
assessing the binding of substrate and intermediates reveals an
intermediate conformation binds substrate most favourably.
Fig. 4 Active site architecture and the effect of domain motion. a Left: Active site composition of closed ShVdcCD shows limited direct contribution of
VdcD (I60) to the active site architecture. Residues coloured by domain as in Fig. 3. prFMN modelled in dark green from Rosetta Ligand Docking. Right:
Juxtaposition of Fdc1 active site shows similar overall architecture to the active site, with residues key for Fdc1 catalysis (E282, R173, E277, L439)
conserved between the enzymes. b Energy profile of docking models along the trajectory of domain closure. Energy minima of PHB and vanillic acid binding
to VdcCD with previously docked prFMN are found when R-L distances are 11.6 and 13.4 Å respectively. Int2 shows lowest binding energies to most open
models, whereas Int3Quinoid shows lowest binding energies at an R-L distance of 10 Å. c Modelled substrate binding modes identified by docking with
AutoDock Vina. Bottom images 90° rotation about X axis. Cyan prFMN – Fdc1 (6TIB), magenta prFMN – ShVdcCD Rosetta ligand docking to closed
structure. Left: PHB lowest energy binding (dark blue) found when R-L distance is 11.6 Å, and binding mode (light blue) most similar to naphthoic acid
(green) in Fdc1 found when R-L distance is 10.4 Å. Right: Vanillic acid lowest energy binding (dark grey) found when R-L distance is 13.4 Å, and binding
mode (light grey) most similar to naphthoic acid (green) in Fdc1 found when R-L distance is 10 Å. d Kinetic solvent viscosity effects observed for PHB
decarboxylation performed in 45% glycerol or 40% sucrose compared to buffer without viscosogen. Non-linear regression fit to Michaelis-Menten kinetics
using Prism 9. Kmapp does not vary significantly between samples (within 95% confidence limits). n= 3 (buffer) n= 2 (glycerol and sucrose) technical
replicates, all replicates shown. Similar trends were seen in two independent replicates. The inset shows calculated kcatapp plotted against relative viscosity
(η) revealing a significant decrease in catalytic rate constant with increasing viscosity. Values of η estimated from literature51. Data shown as mean, with
error bars showing 95% confidence limits.
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Further domain closure effectively brings prFMN and substrate
together and favours binding of the Int1/Int3Quinoid states. The
sp3 to sp2 transition of the substrate Cα concomitant with dec-
arboxylation can be accommodated by opening of the active site.
Re-aromatisation thus drives formation of the highly stable Int2
species and domain opening. If the energetics of domain closure
are such that the open-closed equilibrium is poised towards the
closed state, this would provide a means to exert strain on Int2 by
domain closure and avoid formation of dead-end intermediates.
The kinetic solvent viscosity effects observed for PHB decarbox-
ylation align with the proposed dynamic model for VdcCD cat-
alysis. It is likely that (de)carboxylation of other aromatic acids,
although not necessarily progressing through a quinoid inter-
mediate, requires similar active site mobility to accompany for-
mation of and interconversion between covalent prFMN adducts.
UbiD enzyme activity is often found to be oxygen sensitive,
with the exception of family members acting upon acrylic (Fdc1)
or heteroaromatic substrates (PA0254). Both Fdc1 and PA0254
form dimers16,41, in contrast to the more frequently observed
hexameric nature of the aromatic acid decarboxylases18,20. Fur-
thermore, there is little evidence that large scale domain motion
occurs for the dimeric holo-enzymes or is involved in catalysis. In
contrast, based on our work with VdcCD, it appears domain
motion is integral to enzyme turnover for aromatic acid (de)
carboxylation. It is possible the open state preferentially popu-
lated by the hexameric holo-enzymes is markedly different in
oxygen sensitivity compared to the closed state readily observed
for the dimeric UbiD enzymes. Furthermore, the prFMN reac-
tivity is likely to be modulated by the protein environment, in
particular residues that interact with the O1 position. In the case
of the oxygen sensitive UbiD enzymes, these include positively
charged residues (i.e. Arg/Lys/His), while for those apparently
unaffected by oxygen, hydrogen bonding partners are Asn or Gln
residues. This difference in active site composition may be
responsible for the ability to decarboxylate acids fused directly to
the aromatic ring, at the expense of stability in aerobic conditions.
Indeed, evolved variants of the oxygen tolerant Fdc1 have been
reported to undergo oxygen mediated inactivation10, suggesting
active site properties influence oxygen sensitivity.
The rational engineering of ShVdcCD to accept syringic acid
using L182V provides further evidence that UbiD enzymes can be
evolved, but also suggests further studies will need to take into
account the effect mutations might have on the protein dynamical
behaviour. In conclusion, domain dynamics coupled to catalysis
provides a solution to some of the challenges faced by aromatic
acid UbiD decarboxylases. Appropriate choreography between
domain dynamics and catalysis is likely essential to achieve rapid
turnover, by accommodating large scale motion of the substrate
aromatic moiety and manipulating the internal thermodynamics
to avoid the pitfall of an excessively stable Int2 species. This
certainly would be the case of very challenging substrates such as
benzene or naphthalene14,15. Indeed, while rational engineering
of the dimeric Fdc1 has led to some success in expanding the
substrate scope, Fdc1 mediated naphthoic acid decarboxylation
Fig. 5 VdcCD catalysis requires large scale domain motion. Proposed VdcCD mechanism shown with structures to the left showing the lowest energy
configuration of substrate and intermediates bound in ShVdcCD active site (prFMN depicted in magenta, and substrate/adducts depicted in green). The
structures to the right show the corresponding monomer conformation, overlayed on the closed structure (in translucent grey). Supplementary movie 3
illustrates the domain motions seen between intermediates.
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remains very slow5. It seems likely the lack of significant domain
motion in Fdc1 will need to be addressed in order to achieve
improved catalytic rates.
Methods
Cloning, mutagenesis, and cell growth. Sedimentibacter hydroxybenzoicus vdcC
and vdcD genes were codon optimized for E. coli expression and synthesised by
GeneArt (ThermoFisher), Bacillus subtilis vdcC and vdcD were codon optimized for
E. coli expression and synthesised by GenScript. C-terminal His tag constructs of
the C subunits were made in pET30a between NdeI and XhoI restriction sites.
N-terminal His tag constructs of D subunits were made in pET28a between NdeI
and XhoI restriction sites. Untagged constructs of both C and D subunits were
made in pET21a between NdeI and XhoI. A construct of untagged PaUbiX in
pCDF-Duet was used6. These constructs were made to allow different combina-
tions of vectors to be used with different antibiotic resistances to maintain selection
pressures.
The genes were amplified using the PCR primers detailed in Supplementary
Table 2.
The empty vectors were cut using restriction enzymes purchased from NEB. In-
Fusion (Takara) ligation independent cloning was used to insert the fragments into
cut vectors. Stellar cells (Takara) were transformed with the product, and insertion
was confirmed by sequencing (Eurofins) following MiniPrep (Qiagen) of overnight
cultures of single colonies.
Mutants were produced by using Q5 mutagenesis (NEB) as per the
manufacturers protocols, using the primers in Supplementary Table 2. Mutation
was confirmed by sequencing.
BL21(DE3) cells (NEB) were transformed with plasmid in the combinations
denoted in Supplementary Table 3.
BL21(DE3) strains were grown at 37 °C, 180 rpm shaking in 1 L conical flasks of
Terrific Broth (Formedium) with 0.4% (v/v) glycerol added, along with 50 mg L−1
of the appropriate antibiotic(s). Cells were induced with 0.25 mM IPTG when
OD600nm reached 0.8, at which point the temperature was reduced to 18 °C
overnight. Cells were harvested after typically 18 h of induction by centrifugation at
7000 × g for 10 min in a Beckman JLA8.1000 rotor.
Purification. Cells were resuspended in buffer A (50 mM Hepes, 300 mM NaCl,
pH 7.5) with SigmaFAST EDTA free protease inhibitor cocktail tablet added,
0.1 mg mL−1 DNase and RNase were both added to the cell suspension (all Sigma).
Cells were lysed using a Constant Systems cell disruptor at 20 kPsi. Lysate was
clarified by centrifugation at an average 184,000 × g for 1 h in a Beckman Type
50.2Ti rotor. Using an AKTA Pure (GE Healthcare), the lysate was applied to a
pre-equilibrated 5 mL HisTrap-HP (GE Healthcare) column and was washed with
5 CV buffer A. A gradient of buffer A to buffer A containing 250 mM imidazole
was run over 30 CV and collected in 1 mL fractions. Proteins eluted in a single peak
and were run on an SDS PAGE gel for confirmation of purity. Fractions containing
the desired protein were concentrated using Sartorius Vivaspin concentrators, and
subjected to gel filtration using a Superdex 200 10/300 GL column (GE Healthcare),
in 20 mM Hepes, 150 mM NaCl, pH 7.5 to remove any excess VdcD and to ensure
1:1 stoichiometry.
For protein prepared for crystallisation, the ShVdcCDN/ShVdcCDV59X
complexes were further purified after IMAC. The fractions from Ni-IMAC were
pooled and concentrated, prior to a 6-fold dilution using 50 mM Hepes, pH 7.5 to
dilute NaCl to 50 mM. Using an AKTA Pure (GE Healthcare), the complex was
applied to a 5 mL HiTrapQ-HP (GE Healthcare) column and was washed with 5
CV 50 mM Hepes, 50 mM NaCl, pH 7.5. A gradient of 50 mM − 1M NaCl was
run over 30 CV, in a constant buffer of 50 mM Hepes pH 7.5. The peak containing
the complex was pooled, concentrated, and subjected to gel filtration using a
Superdex 200 10/300 GL column (GE Healthcare), in 20 mM Hepes, 150 mM
NaCl, pH 7.5. The protein was concentrated in Vivaspin concentrators (Sartorius)
and crystal trials were immediately performed.
Protein concentrations were estimated using A280nm extinction coefficients
calculated by the ExPASy ProtParam tool: ShVdcC ε= 57300M−1 cm−1, BsVdcC
ε= 58790M−1 cm−1, ShVdcD, ShVdcDV59X, and BsVdcD ε= 13980M−1 cm−1,
ShVdcCD ε= 71280M−1 cm−1, BsVdcCD ε= 72770M−1 cm−1.
HPLC activity assays. All HPLC assays were prepared in an anoxic chamber (Belle
Technologies) in a nitrogen atmosphere. prFMN was made as per previous
protocols42; 50 µM UbiX11, 5 µM Fre reductase43, 1 mM FMN, 5 mM DMAP, and
5 mM NADH were combined in an anaerobic chamber and left for 2 h to allow
prFMN production before filtration through a 10 kDa MWCO centrifugal con-
centrator (Sartorius) to remove UbiX and Fre proteins prior to addition to Vdc
assays.
Initial assays were performed with substrates (4-hydroxybenzoic acid (PHB)
and vanillic acid) dissolved to 10 mM in 100 mM KPi, pH 6; substrates were not
purged of oxygen before introduction to the anaerobic chamber. VdcC, VdcD or
both were mixed with prFMN and MnCl2 in a 1:2:2 (protein: prFMN: MnCl2) in an
anaerobic chamber and were added to substrate to a final concentration of 10 µM
protein (both VdcC and VdcD 10 µM when added in combination), and diluted to
a final substrate concentration of 5 mM. The reaction was allowed to proceed
overnight (18 h) in the anaerobic chamber before being removed to aerobic
conditions and quenched by the addition of 1 volume equivalent of
acetonitrile+ 0.2% trifluoroacetic acid (TFA). The samples were centrifuged at
14,000 × g for 10 min to removed precipitated protein. The resulting supernatant
was diluted 2.5 fold before being subjected to HPLC in isocratic 50% acetonitrile,
50% water, 0.1% TFA on a Phenomenex Kinetex 5 µm C18 100 Å 250 × 4.6 mm LC
Column. Peaks were identified by running standards of substrate and expected
product and quantified by running a standard concentration curve of these
compounds. A control of substrate with 20 µM prFMN was made to ensure there
were no side reactions arising from the prFMN reconstitution mix. Samples were
run in duplicate.
Assays for the substrate scope experiments were set up in an identical manner,
with the exception of adding a 2-fold excess of VdcD to VdcC in cross-activation
studies. In all assays the concentration of the C subunit was maintained at 10 µM.
Data were analysed and peaks integrated using Agilent Chemstation (Version
(B.04.03).
VdcC:VdcD Stoichiometry effect assays. The effect of varied stoichiometry was
investigated by the anaerobic reconstitution of ShVdcC in the presence of 0.2 and 4
molar equivalents of ShVdcD. ShVdcC and ShVdcD were mixed with prFMN/
MnCl2, giving constant concentrations of 50 µM and 200 µM for ShVdcC and
prFMN/MnCl2 respectively, and a concentration of either 10 µM or 200 µM for
ShVdcD. The activity was assayed in anoxic conditions on a Cary 60 UV–vis
Spectrophotometer (Agilent) using the Kinetics software (Version 5.0.0.999)
measuring the change in absorbance at 247 nm using 100 µM PHB, and
adding VdcC to a concentration of 0.25 µM. Substrate was not purged of oxygen
prior to activity assays. The measurements were taken over a period of 3 h in
triplicate.
Aerobic decay. To measure the aerobic activity decay, ShVdcCD was first rendered
anaerobic by desalting into 20 mM Hepes, 150 mM KCl, pH 7.5 in an anaerobic
chamber using a GE Healthcare PD-10 Mini desalting column. prFMN (produced
as described above) and MnCl2 were added in 2 fold excess. The mixture was left
for 10 min prior to desalting into the same buffer. A total of 100 µL of active
protein was removed from the anaerobic environment in an opaque tube (to ensure
no light mediated effects) and the activity was measured every 15 min over a
90 min period using 100 µM PHB in 50 mM NaPi, 50 mM KCl, pH 6, measuring
the decrease in absorbance at 247 nm in a Agilent Cary 60 Spectrophotometer
using the Kinetics software (Version 5.0.0.999). The protein was constantly exposed
to oxygen by leaving the tube open throughout the time course. After 90 minutes
the remaining protein was reintroduced to the anaerobic chamber, and a 2-fold
excess of prFMN was added. The protein was removed from the chamber, and
immediately assayed for activity. The process was performed in duplicate.
Kinetic solvent viscosity effects (KSVEs). To measure KSVEs, PHB was dis-
solved in 50 mM NaPi, 50 mM KCl, pH 6, and added to stock solutions of buffered
viscosogen (50 mM NaPi, 50 mM KCl, pH 6) to a final PHB concentration of
10 mM, and viscosogen concentrations of 45% glycerol and 40% sucrose. The pH
of PHB/viscosogen stock solutions were measured to ensure no variation from pH
6. The PHB stocks were mixed with buffered viscosogen to generate the dilution
series required for obtaining kinetic parameters.
prFMN was produced in vitro as described above, and was added to ShVdcCD
in a substoichiometric ratio with excess MnCl2 (0.5 prFMN: 1 ShVdcCD: 2 MnCl2).
This was performed so the final concentration of prFMN (assuming complete
turnover in the UbiX reaction) can be considered Et for calculations (i.e. [active
protein]= [prFMN]). The mixture was diluted to Etapp= 30 µM with a mixture of
aerobic and anaerobic buffers (1:3 ratio) and left overnight in the anaerobic
chamber to allow full oxidative maturation in trace oxygen.
Rates were measured using the decrease in absorbance at 247 nm in an Agilent
Cary 60 Spectrophotometer in the Kinetics software (Version 5.0.0.999), using
Eppendorf UVette® cuvettes. While measuring rates at [PHB] ≤100 µM, a 1 cm
pathlength was used; at ≥250 µM a 0.2 cm pathlength was used to allow absorbance
in the linear range. ShVdcCDprFMN was added to 100 µL PHB and agitated
vigorously.
Crystallography. Crystal trials were attempted with both BsVdcCD and ShVdcCD
following purification. Trials were produced in Molecular Dimensions’ PACT-
Premier, JCSG-Plus, Morpheus, SG1, LMB, and BCS screens. Using a TTP Labtech
Mosquito, protein was mixed in a 1:1 ratio with reagent, in 600 nL sitting drops
with 30 µL reservoir solution. Three concentrations of protein were screened in
SWISSCI 3 Lens plates, at 20, 10, and 5 mgmL−1. BsVdcCD was found to crys-
tallise in a number of conditions, however, diffraction was insufficient. ShVdcCD
was found to crystallise in multiple conditions, with the best diffracting crystals
found in JCSG-Plus D3 (0.2 M Sodium chloride, 0.1 M sodium/potassium phos-
phate, pH 6.2, 50% v/v PEG200) (F222-Closed), BCS H2 (0.1 M Hepes, pH 7.5,
30% v/v PEG Smear low) (P1-Open), and JCSG-Plus B8 (0.2 M Magnesium
chloride hexahydrate, 0.1 M Tris, pH 7, 10% PEG 8000) (P212121-ShVdcCDV59X).
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The ShVdcCDV59X crystal was cryoprotected with 10% PEG 400 prior to flash
cooling in liquid N2. F222 and P1 wild type ShVdcCD crystals were flash cooled
and required no further cryoprotecting due to components in the crystallisation
conditions. Data were collected on Diamond Light source beamlines i03 (F222),
i04-1 (P1), and i24 (V59X) and processed with xia244 (P1 and F222) or xia2
dials45(P212121) using beamline automated data processing. Structures were solved
using molecular replacement, using Phaser MR46, with UbiD as a search model.
Two ensembles were used to solve the structure, firstly the hexameric core of the
oligomerisation domains was used as a single search model (UbiD residues
334–465 arranged in the hexamer), followed by the search for six prFMN binding
domains (UbiD residues 1–333). The F222 model was initially built using
phenix.autobuild47, prior to manual model building in Coot48. The model was
refined using phenix.refine49, interspersed with manual model building. The closed
model was then used in molecular replacement of the open structures (P1,
P212121), using the same strategy as was used for solving the closed structure. The
models were then refined and built using phenix.refine and coot. The models and
data were deposited in the PDB under the accession codes (Closed–7AE4,
Open–7AE5, ShVdcCDV59X–7AE7). Data processing statistics, along with refine-
ment statistics are in Table 1.
Modelling and docking. The prFMN binding domains of the two states were
aligned on secondary structure, prior to a Morph being calculated using UCSF
Chimera 1.13.137. Analysis showed that the largest motions were from the closure
of the domains, however, loop motions around the prFMN binding pocket were
observed, with the closed state closely resembling crystal structures in which
prFMN can be seen binding. Therefore, a hybrid model was constructed, with the
prFMN binding domain (residues 1–323) of the closed structure being used in
conjunction with the oligomerisation domain of the open structure to create an
open model with the prFMN binding pocket in an appropriate conformation. A
new morph was performed, with the trajectory of the oligomerisation domain
being plotted in 16 models, allowing an approximate 2° iterations of the motion.
Cartesian coordinates for the Int2 and Int3Quinoid intermediates with the simplest
substrate (PHB) were built from previous DFT models of prFMN-substrate
adducts17 and were optimised using Gaussian 09 revision D.01 at the B3LYP/6-
311+ +G(d,p) level of theory with the D3 version of Grimme’s dispersion with
Becke–Johnson damping50 and a generic polarizable continuum model with a
dielectric of 5.7. These intermediates were docked into the 16 morph models using
AutoDock Vina38. To ensure only the effect of domain closure was being observed,
all residues were restricted to a single conformer.
Substrate and product docking was performed using the coordinates described
above, with prFMN present in the position as determined by Rosetta Ligand
Docking35. For PHB docking E278 was allocated an allowed rotamer to prevent
occlusion of the substrate carboxylate binding pocket.
Docking of Int2 and Int3Quinoid resulted in single binding poses in each of the
sixteen models. Where substrates and product were docked, multiple poses were
observed. In these instances, the pose with the lowest energy for the correct
orientation (of substrate/product carboxy and hydroxy groups based on prior
knowledge) was selected to resemble a likely catalytically relevant species.
Models and ligand co-ordinates used for docking are available at https://doi.org/
10.5281/zenodo.5101186, along with binding energies calculated by
Autodock Vina.
ElNémo was used to assess the low frequency normal mode analysis of domain
motion from crystal structures. Both open and closed structures were analysed.
Parameters were set as default, with the exception of NRBL= 5, and
DQMIN=−200, DQMAX= 200.
Table 1 X-ray crystallography data collection and refinement statistics.
7AE4 (Closed) 7AE5 (Open) 7AE7 (V59X)
Wavelength (Å) 1.284 0.9159 0.9686
Resolution range (Å) 64.05−3.31 (3.428−3.31) 63.87−2.19 (2.268−2.19) 71.23−2.66 (2.755−2.66)
Space group F 2 2 2 P 1 P 21 21 21
Unit cell Å ° 270.92 320.55 326.23 90 90 90 98.23 108.3 111.42 117.72 101.32 91.8 101.553 200.945 201.991 90 90 90
Total reflections 783105 (80789) 350629 (34881) 2553323 (157443)
Unique reflections 104765 (10415) 197121 (19440) 119016 (11673)
Multiplicity 7.5 (7.8) 1.8 (1.8) 21.5 (13.5)
Completeness (%) 99.94 (99.98) 97.03 (95.74) 99.85 (98.96)
Mean I/sigma(I) 13.95 (1.52) 6.59 (1.42) 8.25 (2.79)
Wilson B-factor Å2 126.16 43.17 37.25
R-merge 0.1062 (1.554) 0.05937 (0.563) 0.3177 (0.845)
R-meas 0.1141 (1.665) 0.08396 (0.7962) 0.3253 (0.8782)
R-pim 0.04155 (0.5936) 0.05937 (0.563) 0.06934 (0.2302)
CC1/2 0.998 (0.511) 0.984 (0.445) 0.988 (0.618)
CC* 1 (0.822) 0.996 (0.785) 0.997 (0.874)
Reflections used in refinement 104747 (10413) 197043 (19412) 118974 (11673)
Reflections used for R-free 5121 (479) 9805 (1007) 5811 (531)
R-work 0.1625 (0.2993) 0.2233 (0.3399) 0.1799 (0.2609)
R-free 0.1974 (0.3295) 0.2625 (0.3651) 0.2268 (0.3235)
CC (work) 0.942 (0.744) 0.938 (0.626) 0.926 (0.811)
CC (free) 0.932 (0.698) 0.911 (0.552) 0.929 (0.685)
Number of non-hydrogen atoms 25697 25337 24349
macromolecules 25588 24515 23802
ligands 175 18 11
solvent None 804 536
Protein residues 3257 3192 3146
RMS (bonds) (Å) 0.004 0.003 0.03
RMS (angles) (°) 0.64 0.62 0.66
Ramachandran favored (%) 95.48 96.7 97.45
Ramachandran allowed (%) 4.52 3.27 2.51
Ramachandran outliers (%) 0 0.03 0.03
Rotamer outliers (%) 0 1.04 1.34
Clashscore 12.04 5.81 5.72
Average B-factor (Å2) 130.56 56.9 45.55
macromolecules 130.53 57.18 45.7
ligands 138.43 75.04 53.65
solvent None 48.18 38.76
Number of TLS groups 1 82 1
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The atomic coordinates and structures factors (codes 7AE4, 7AE5, and 7AE7) have been
deposited to the Protein Data Bank (http://www.pdb.org). Graphical data presented here
is available in the source data file. Modelling data is available at https://doi.org/10.5281/
zenodo.5101186. Publicly available data used in this study is available from the Protein
Data Bank under the accession codes: 4ZA4, 5O3M, 5O3N, 5NY5, 5M1C, 5M1D, 6H6V,
6DA6, 6DA7, 6DA9, 7ABN Source data are provided with this paper.
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